Rishi P. Singh, MD, and Dante Pieramici, MD, discuss the benefits of photodynamic therapy (PDT) and methods of effective delivery. Drs. Singh and Pieramici also discuss real-world clinical scenarios where PDT was beneficial.
This activity is supported by an unrestricted educational grant from Bausch + Lomb.
Upon completion of this activity, the participant should be able to:
Provided by Evolve Medical Education
Accreditation Statement
Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
Evolve designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 11 for Windows
Edge (recent versions; Chromium-based) for Windows
Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Safari (recent versions) for Mac OSX, or iOS
Hardware Requirements:
4GB+ RAM
Recommended internet speed 5Mbps+
Dante Pieramici, MD
Co-director
California Retina Research Foundation
Partner, California Retina Consultants
Member, Retina Consultants of America
Rishi P. Singh, MD
President
Cleveland Clinic Martin North and South Hospitals
Cleveland Clinic Florida Center for Ophthalmic Bioinformatics
Cole Eye Institute Cleveland Clinic Foundation
Stuart, FL
Professor of Ophthalmology
Lerner College of Medicine, Case Western Reserve University
Cleveland, OH
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Dante Pieramici, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Genentech, Regeneron, REGENXBIO, Adverum Biotechnologies, Iveric Bio, NGM Biopharmaceuticals, Gemini Therapeutics, Unity. Grant/Research Support: Genentech, Regeneron, REGENXBIO, Adverum Biotechnologies, Iveric Bio, NGM Biopharmaceuticals, Gemini Therapeutics, Unity, Stealth BioTherapeutics, Kodiak Sciences, Apellis, Ocular Therapeutix. Speaker's Bureau: Genentech and Regeneron.
Rishi P. Singh, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon Vision, AsclepiX Therapeutics, Bausch + Lomb, Carl Zeiss Meditec, EyePoint Pharmaceuticals, Genentech, Graybug, Gyroscope, Novartis, and Regeneron.
The Evolve staff, planners, and reviewers have no financial relationships with ineligible companies.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve and Bausch + Lomb.
Release Date:
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Eric D. Donnenfeld, MD
Marjan Farid, MD
Jason J. Jones, MD
Eva I. Liang, MD, FACS
Carlton Yuen, MD
